Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
3(20%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
5
33%
Ph phase_2
5
33%
Ph early_phase_1
1
7%
Ph phase_1
1
7%
Ph phase_3
2
13%
Ph phase_4
1
7%

Phase Distribution

2

Early Stage

5

Mid Stage

3

Late Stage

Phase Distribution15 total trials
Early Phase 1First-in-human
1(6.7%)
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
5(33.3%)
Phase 3Large-scale testing
2(13.3%)
Phase 4Post-market surveillance
1(6.7%)
N/ANon-phased studies
5(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(5)
Terminated(2)
Other(4)

Detailed Status

Completed5
unknown4
Recruiting2
Terminated1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (6.7%)
Phase 11 (6.7%)
Phase 25 (33.3%)
Phase 32 (13.3%)
Phase 41 (6.7%)
N/A5 (33.3%)

Trials by Status

recruiting213%
terminated17%
unknown427%
withdrawn17%
completed533%
not_yet_recruiting17%
active_not_recruiting17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07423663Early Phase 1

Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions

Active Not Recruiting
NCT07093346Not Applicable

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Recruiting
NCT06955975Not Applicable

The Effect of Pectin Supplementation on Geriatric With Frailty: A Randomised Placebo-Controlled Dietary Intervention Study

Recruiting
NCT06580132Not Applicable

The Effects of Dietary Fibres on Metabolic Health and the Gut Microbiome

Completed
NCT06531993Phase 2

Effect of Pectin in Chronic Kidney Disease Patients ( Stage 3 and 4 )

Not Yet Recruiting
NCT04114513Not Applicable

Dietary Fibers Effect on the Gut Microbiota Composition

Withdrawn
NCT04381871Phase 2

Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients

Unknown
NCT04191213Phase 2

Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients

Unknown
NCT04215380Not Applicable

Effects of Gum Arabic Ingestion on Hormonal and Metabolic Changes in Patients With Polycystic Ovary Syndrome

Unknown
NCT02194972Phase 3

Clinical Effects of Soluble Dietary Fiber Supplementation

Completed
NCT02164877Phase 2

Effect of Soluble Dietary Fiber on Bacterial Translocation in Crohn's Disease

Terminated
NCT02376270Phase 4

Pectin, Aging and Intestinal Barrier Function

Completed
NCT02270268Phase 3

Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome

Completed
NCT02291354Phase 2

Evaluating the Synergism of Soluble Dietary Fiber With Fecal Microbiota Transplantation in Slow Transit Constipation

Unknown
NCT02379624Phase 1

Pectin Start Early Enteral Nutritional Support in Critically Ill Patients

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15